An association of virus infection with type 2 diabetes and Alzheimer's disease

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 3, 2014, Pages 429-439

  Karim, Sajjad ^a   Mirza, Zeenat ^a   Kamal, Mohammad A ^a   Abuzenadah, Adel M ^a   Azhar, Esam I ^a   Al Qahtani, Mohammed H ^a   Sohra, Sayed S ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Alzheimer's disease; Hepatitis virus; Herpes simplex virus; Influenza virus; Type 2 diabetes mellitus; Virus infection

Indexed keywords

CAPSID PROTEIN; DNA; GLYCOPROTEIN; LIPID; VIRUS PROTEIN; VIRUS RNA;

ALZHEIMER DISEASE; BORNA DISEASE VIRUS; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTEROVIRUS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFLUENZA VIRUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATHOLOGY; PICORNAVIRUS; REVIEW; RISK FACTOR; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ANIMAL; CLASSIFICATION; COMPLICATION; DIABETES MELLITUS, TYPE 2; VIROLOGY; VIRUS DISEASES;

ALZHEIMER DISEASE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; VIRUS DISEASES;

EID: 84904505410     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113126660164     Document Type: Review

References (184)

1. Terry Jr AV, Callahan PM, Hall B, Webster SJ. Alzheimer's Disease and Age-Related Memory Decline(Preclinical). Pharmacol Biochem Behav 2011; 99(2): 190-210.
2. Hamden K, Jaouadi B, Salami T. Modulatory effect of fenugreek saponins on the activities of intestinal and hepatic disaccharidase and glycogen and liver function of diabetic rats. Biotechnol Bioproc E 2010; 15: 745-53.
3. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378(9785): 31-40.
4. WHO: Global status report on noncommunicable diseases 2010. Geneva, World Health Organization, 2011.
5. Thrower SL, Bingley PJ. What is type 1 diabetes? Medicine 2010; 38: 592-6.
6. Heydari I, Radi V, Razmjou S. Chronic complications of diabetes mellitus in newly diagnosed patients. Int J Diabet Mellit 2010; 2: 61-3.
7. Lehuen A, Diana J, Zaccone P. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010; 10: 501-13.
8. Kumar V, Fausto N, Abbas AK, Cotran RS, Robbins SL. Robbins and Cotran Pathologic Basis of Disease(7th ed.): Philadelphia, PA, 2005; pp. 1194-5.
9. Farres J, Albert P, Mireia C, et al. Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet. Nutr Metab 2010; 7: 88.
10. Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med 2007; 120: 829-34.
11. Vijan S. Type 2 diabetes. Ann Intern Med 2010; 152(5): ITC3: 1-15.
12. Haan MN. Therapy Insight: type 2 diabetes mellitus and the risk of late onset Alzheimer's disease. Nat Clin Pract Neurol 2006; 2(3): 159-66.
13. Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010; 67: 5050-12.
14. Priyadarshini M, Kamal MA, Greig NH, et al. Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase. CNS Neurol Disord Drug Targets 2012; 11(4): 482-9.
15. Biophysical society. 2013; February 1. Type II diabetes and Alzheimer's connection. Science Daily. Available from: http: //www.sciencedaily.com-/releases/2013/02/130201095945.htm
16. Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging 1998; 19(3): 173-89.
17. Wolfe MS. Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential. J Med Chem 2001; 44: 2039-60.
18. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-66.
19. Nunan J, Williamson NA, Hill AF, et al. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease betaamyloid protein precursor: effect of C-terminaltruncation on production of beta-amyloid protein. J Neurosci Res 2003; 74: 378-85.
20. Brookmeyer R, Johnson E, Ziegler GK, Arrighi MH. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3(3): 186-91.
21. World Alzheimer's Report, 2012: Available form: http: //www.alz.co.uk/research/WorldAlzheimerReport
22. Clinical Trials. Found 1012. Studies with search of: Alzheimer. US National Institutes of Health. Retrieved 01-10-2011.
23. Luchsinger JA. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63(7): 1187-92.
24. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004; 82(8): 510-29.
25. Pasquier F. Diabetes and cognitive impairment: how to evaluate the cognitive status?. Diabetes Metab 2010; 36(Suppl 3): S100-5.
26. Shoback D, David GG. Greenspan's basic & clinical endocrinology. 9th ed. McGraw-Hill Medical, New York, 2011; p. 14.
27. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Phys 2009; 79(1): 29-36.
28. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009; 48(1): 44-51.
29. Carter CJ. Alzheimer's Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner. Int J Alzheimers Dis 2010a; 140539.
30. Carter CJ. Familial and late-onset Alzheimer's disease: Evidence for an auto-immune component triggered by viral, microbial and allergen antigens with homology to beta-amyloid and APP mutant peptides. Nat Preced 2010b; 1: 4662.
31. Cadranel JF, Di Martino V, Lambrey G, et al. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. Eur J Gastroenterol Hepatol 2008; 20: 829-36.
32. Dienstang JL, Isselbacher KJ. Acute viral hepatitis. In: Kasper DL, Braunwald E, Fauci AS, Eds. Harrison's Principles of Internal Medicine; 16th edn.; McGraw-Hill, New York 2005; pp.1825-55.
33. Alter MJ, Kruszon MD, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
34. Ryan KJ, Ray CG. Sherris Medical Microbiology; 4th edn.; McGraw Hill; New york 2004; pp. 566-9.
35. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
36. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Vir Hepat 2008; 48(5): 1420-9.
37. Joyce MA, Walters KA, Lamb SE, et al. HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice. PLoS Pathog 2009; 5(2): e1000291.
38. Clement S, Pascarella S, Negro F. Hepatitis C Virus Infection: Molecular Pathways to steatosis, Insulin resistance and oxidative stress. Virus 2009; 1: 126-43.
39. Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48-55.
40. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902): 359-62.
41. Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 241-54.
42. Bartenschlager R, Frese M, Pietschmann T. Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 2004; 63: 71-180.
43. Gale MJ, Blakely SM, Kwieciszewski B, et al. Hepatitis C virus non-structural 5a protein. Mol Cell Biol 1998; 18: 5208-18.
44. Miyamoto H, Moriishi K, Moriya K, et al. Involvement of the PA28 Dependent Pathway inInsulin Resistance induced by Hepatitis C Virus Core Protein. J Virol 2007; 81(4): 1727-35.
45. Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther 2013; 37: 647-52.
46. Solomon A, Solomon A, Adane M, Tamrat A. Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control Study. Interdisciplin Persp Infect Dis 2012; 7: 354656.
47. Gutierrez YG, Gadalupe PRM, Nahum MS. Viral hepatitis infection and insulin resistance: A review of the pathophysiological mechanisms. Salud Pública Mex 2011; 53 (1): S46-51.
48. Saxena AK, Suresh RB. An intriguing relationship between type 2 diabetes mellitus and hepatitis C virus infection: the renal perspective. Hepat Monthly 2009; 9(2): 89-91.
49. Fabrizi FP, Lampertico G, Lunghi S, Mangano F, Aucella PM. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation. Aliment Pharmacol Ther 2005; 21: 623-32.
50. Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003; 38: 50-6.
51. Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol 2009; 15: 1537-47.
52. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
53. Simon R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
54. Venessa P, Jenny H. Hepatitis C and diabetes: one treatment for two diseases? Liver Int 2010; 30(3): 356-64.
55. Parvaiz F, Sobia M, Huma T, et al. Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance. Virol J 2011; 8: 474.
56. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-9.
57. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
58. Moucari R, Asselah T, Cazals-Hatem D. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4: serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-23.
59. Kamal MA, Tan Y, Seale JP, Qu X. Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease. Neurochem Res 2009; 34(12): 2163-9.
60. Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between noninsulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
61. Grimbert S, Valensi P, Levy MC. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996; 20: 544-8.
62. Vincent W, Wang S. Hepatitis C virus infection and diabetes: Not a straight forward relationship. J Gastroenterol Hepatol 2012; 27: 1688-94.
63. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008; 49: 831-44.
64. Cho N, Joon WM, Syed IA, Mala M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Metaanalysis. World J Gastroenterol 2012; 18(14): 1642-51.
65. Rouabhia S, Rachid M, Hocine B, et al. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol 2010; 16(27): 3427-31.
66. Romero-Gomez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12: 7075-80.
67. Arao M, Murase K, Kusakabe A, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355-60.
68. Waki K, Noda M, Sasaki S, et al. JPHC Study Group. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population based prospective study in the JPHC study cohort I. Diabet Med 2005; 22: 323-31.
69. Ozylkan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1996; 91: 1480-1.
70. Parolin MB, Rea R, Vargas RM, et al. Prevalence of hepatitis C infection in patients with type 2 diabetes mellitus. Arq Gastroenterol 2006; 43: 77-80.
71. Naing CJ, Wah M, Syed IA, Mala M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Metaanalysis. World J Gastroenterol 2012; 18(14): 1642-51.
72. Singhal AK, Ayoola AE. Prevelance and factors affecting occurrence of type 2 diabetes mellitus in saudi patients with chronic liver disease. Saudi J Gastroenterol 2008; 14(3): 118-21.
73. Akbar DH, Siddique AM, Ahmed MM. Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med Princ Pract 2002; 11(2): 82-5.
74. Chiu SL, Chen CM, Cline HT. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 2008; 58: 708-19.
75. Zhang C, Cai Z, Kim YC, et al. Stimulation of hepatitis C virus(HCV) nonstructural protein 3(NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol 2005; 79: 8687-97.
76. Deans E. Nutrition and Alzheimer's Disease-Dangers of Insulin Resistance and Low Cholesterol. Evol Psychiatry 2011; 1.
77. Miklossy J. Alzheimer's disease -a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 2011; 8: 90.
78. Shintani YH, Fujie HM. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126(3): 840-8.
79. Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS. Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer's disease. J Neurosci Res 2011; 89: 808-14.
80. Capua I, Mercalli A, Pizzuto MS, et al. Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model. J Virol 2013; 87(1): 597-610.
81. Arase Y, Mariko K, Fumitaka S, et al. Effect of Type 2 Diabetes on Risk for Malignancies Includes Hepatocellular Carcinoma in Chronic Hepatitis C. Hepatology 2013; 57(3): 964-73.
82. Rachael R. Type 2 diabetes linked to common virus. My Health News Daily 2012; p. 1.
83. Sarah S. Could a Common Virus Lead to Type 2 Diabetes in Seniors? My Health News Daily 2012; p.1
84. Huang JF, Yu ML, Dai CY, Chuang WL. Glucose abnormalities in hepatitis C virus infection. Kaohsiung J Med Sci 2013; 29(2): 61-8.
85. Richardson SJ, Willcox A, Bone AJ. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52(6): 1143-51.
86. Cheng SB, Ferland P, Webster P, Bearer EL. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 2011; 6(3): e17966.
87. Negro F. Mechanisms of hepatitis C virus-related insulin resistance. Clin Res Hepatol Gastroenterol 2011; 35(5): 358-63.
88. Yuhua S, Weidong P, Yongjian Wu, Yuejin Y. An Association of Herpes Simplex Virus Type 1 Infection With Type 2 Diabetes. Diabetes Care 2005; 28: 2.
89. Roberts BW, Cech I. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J 2005; 98(7): 686-92.
90. Letenneur L, Peres K, Fleury H, et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS ONE 2008; 3(11): e3637.
91. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009; 5(4): 348-60.
92. Dobson CB, Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging 1999; 20(4): 457-65.
93. Pyles RB. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors (PDF). Herpes 2001; 8(3): 64-8.
94. Mettenleiter TC, Klupp BG, Granzow H. Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 2006; 9(4): 423-9.
95. McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res 2006; 117(1): 90-104.
96. Ott A. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53: 1937-42.
97. Kroner, Z. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern Med Rev 2009; 14: 373-9.
98. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-23.
99. Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cycloxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004; 109: 1729-34.
100. Wozniak MA, Frost AL, Itzhaki RF. Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 2009; 16(2): 341-50.
101. Hill JM, Ball MJ, Neumann DM. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol 2008; 82(16): 8230-4.
102. Carter CJ. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem Int 2008; 52(6): 920-34.
103. Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 2005; 75: 300-6.
104. Itzhaki RF, Dobson CB, Wozniak MA. Herpes simplex virus type 1and Alzheimer's disease. Ann Neurol 2004; 55: 299-300.
105. Hemling N, Roytta M, Rinne J, et al. Herpes viruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol 2003; 54: 267-71.
106. Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 2009; 217: 131-8.
107. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF. Herpes viruses in brain and Alzheimer's disease. J Pathol 2002; 197: 395-402.
108. Liedtke W, Opalka B, Zimmermann CW, Lignitz E. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 1993; 116: 6-11.
109. Lin WR, Graham J, MacGowan SM, Wilcock GK, Itzhaki R. Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimer Rep 1998; 1: 173-8.
110. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus Is Present in a Very High Proportion of Brains from Vascular Dementia Patients. Neurobiol Dis 2002; 9: 82-7.
111. Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J. HSV-1 in brain and risk of Alzheimer's disease. Lancet 1998; 351: 1330-1.
112. Itzhaki RF, Lin WR. Herpes simplex virus type I in brain and the type 4allele of the apolipoprotein E gene are a combined risk factor for Alzheimer's disease. Biochem Soc Trans 1998; 26: 273-7.
113. Sanders VJ, Felisan SL, Waddell AE, et al. Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: Preliminary study. Arch Neurol 1997; 54: 954-60.
114. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241-4.
115. Sanders VJ, Felisan S, Waddell A, Tourtellotte AA. Detection of herpes virus in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neuro Virol 1996; 2: 249-58.
116. Itzhaki RF, Maitland NJ, Wilcock GK, Yates CM, Jamieson GA. Detection by polymerase chain reaction of herpes simplex virus type1(HSV1) DNA in brain of aged normals and Alzheimer's disease patients. In: Corain B, Iqbal K, Nicolini M, et al., Eds.; Alzheimer's disease: Advances in clinical and basic research. Chichester, UK, John Wiley & Sons 1993; pp. 97-102.
117. Bertrand P, Guillaume D, Hellauer K, et al. Distribution of Herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer's disease brains: A PCR study. Neurodegeneration 1993; 2: 201-8.
118. Nicoll JA, Love S, Kinrade E. Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis. Neurosci Lett 1993; 157: 215-8.
119. Jamieson GA, Maitland NJ, Craske J, Wilcock GK, Itzhaki RF. Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction. Biochem Soc Trans 1991; 19: 122S.
120. Jamieson GA, Maitland NJ, Wilcock K, Yates CM, Itzhaki RF. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 1992; 167: 365-8.
121. Xu F, Sternberg MR, Kottiri BJ. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296(8): 964-73.
122. Xu F, Lee FK, Morrow RA. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr 2007; 151(4): 374-7.
123. Peter JB, Sevall JS. Review of 3200 serially received CSF samples submitted for type-specific HSV detection by PCR in the reference laboratory setting. Mol Cell Probes 2001; 15(3): 177-82.
124. Ball MJ, Mathews R, Steiner I. Latent HSV 1 virus in trigeminal ganglia: the optimal site forlinking prevention of Alzheimer's disease to vaccination. Neurobiol Aging 2001; 22(5): 705-9.
125. Chiara GD, Maria EM, Rossella S, et al. Infectious Agents and Neurodegeneration. Mol Neurobiol 2012; 46: 614-38.
126. Toma HS, Murina AT, Areaux RG Jr, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Sem Ophthalmol 2008; 23: 249-73.
127. Al-Dujaili LJ, Clerkin PP, Clement C, et al. Ocular herpes simplex virus: How are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol 2011; 6: 877-907.
128. Ball MJ, Lukiw WJ, Kammerman EM, Hill JM. Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement 2012; (12): 1552-5260.
129. Itzhaki RF, Wozniak MA. Alzheimer's disease-like changes in herpes simplex virus type 1 infected cells: the case for antiviral therapy, Rejuvenation Res 2008a; 11(2): 319-20.
130. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis 2008b; 13(4): 393-405.
131. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular β -amyloid accumulation and secretase upregulation. Neurosci Lett 2007; 429(2-3): 95-100.
132. Itzhaki RF, Dobson CB, Lin WR, Wozniak MA. Association of HSV1 and apolipoprotein E-ε4 in Alzheimer's disease. J NeuroVirol 2001; 7(6): 570-1.
133. Alvarez G, Aldudo J, Alonso M, Santana S, Valdivieso F. Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res 2012; 90: 1020-9.
134. Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 2011; 6(10): e25152.
135. Kammerman EM, Neumann DM, Ball MJ, Lukiw W, Hill JM. Senile plaques in Alzheimer's disease brains: Possible association of beta amyloid with herpes simplex virus type 1(HSV-1) Lparticles. Med Hypotheses 2006; 66: 294-9.
136. Meckes DG Jr, Raab TN. Microvesicles and viral infection. J Virol 2011; 85: 12844-54.
137. Bearer EL. HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships. Fut Virol 2012; 7(9): 885-99.
138. Li YY, Cui JG, Hill JM, et al. Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett 2011; 487: 94-8.
139. Lukiw WJ, Cui JG, Yuan LY, et al. Acyclovir or A [beta]42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuro Report 2010; 21: 922-7.
140. Takeda S. Diabetes accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA 2010; 107: 7036-41.
141. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-91.
142. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004; 44: 181-93.
143. Zhang C. Presenilins are essential for regulating neurotransmitter release. Nature 2009; 460: 632-6.
144. Klein WL. Synaptic targeting by Aβ oligomers(ADDLS) as a basis for memory loss in early Alzheimer's disease. Alzheimers Dement 2006; 2: 43-55.
145. Steen E. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63-80.
146. Weiping Han, Cai Li. Linking type 2 diabetes and Alzheimer's disease. PNAS 2010; 107(15): 6557-8.
147. Gewin V. Bats harbour influenza. Nature News 2012. Available from: http://www.nature.com/news/bats-harbour-influenza-1.10112
148. Tong S, Li Y, Rivailler P, et al. A distinct lineage of influenza a virus from bats. Proc Natl Acad Sci USA 2012; 109(11): 4269-74.
149. Pei D, Dai J, Kuang Y, et al. Effect of influenza A virus nonstructural protein 1(NS1) on a mouse model of diabetes mellitus induced by Streptozotocin. Biochem Biophys Res Commun 2012; 419(1): 120-5.
150. WHO 2013. Cumulative Number of Confirmed Human Cases for Avian Influenza A/(H5N1) Reported to WHO, 2003-2011.
151. Mattson MP. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 2004; 3: 105-20.
152. Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 2008; 5: 118-21.
153. Tansey MG, Frank-Cannon TC, McCoy MK, et al. Neuroinflammation in Parkinson's disease: Is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 2008; 1(13): 709-17.
154. Haeman Janga, David B, Katharine SR, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA 2009; 106(33): 14063-8.
155. Crescenzi O, Tomaselli S, Guerrini R, et al. Solution structure of the Alzheimer amyloid β -peptide(1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem 2002; 269(22): 5642-8.
156. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003; 108: 1655-61.
157. Wang F, Zumbrun EE, Huang J, et al. Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons. Virology 2010; 405(2): 269-79.
158. Koichi Y, Arvin AM, Gabriella C, et al. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge, UK: Cambridge University Press 2007.
159. Sweet C. The pathogenicity of cytomegalovirus. FEMS Microbiol Rev 1999; 23(4): 457-82.
160. Offermanns S, Rosenthal W. Encyclopedia of Molecular Pharmacology. 2nd edn.; Springer 2008; pp. 437-8.
161. Kol A, Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc Med 1998; 8: 191-9.
162. Nyenhuis DL, Gorelick PB. Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J Am Geriatr Soc 1998; 46(11): 1437-48.
163. Arvanitakis Z, Hachinski V. Vascular Cognitive Impairment: What Else Do We Need to Learn? In: Terry RD, Katzman R, Bick KL, Sisodia SS., Eds., Alzheimer Disease; 2nd edn.; Philadelphia: Lippincott Williams and Wilkins 2000.
164. Zuckerman AJ. Hepatitis Viruses. In: Baron S, et al. Baron's Medical Microbiology. 4th ed. University of Texas Medical Branch 1996.
165. Te H, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liv Dis 2010; 14(1): 1-21.
166. Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004; 24(Suppl 1): 3-10.
167. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res 2007; 127(2): 164-76.
168. Custro N, Carroccio A, Ganci A. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001; 1: 476-81.
169. Wang CC, Hsu CS, Liu CJ. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008; 23: 779-82.
170. Kim KH, Shin HJ, Kim K. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR gamma. Gastroenterol 2007; 132: 1955-67.
171. Li L, He Y, Yang H. Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 inShenzhen, People's Republic of China. J Clin Microbiol 2005; 43(8): 3835-9.
172. Nash D, Mostashari F. The outbreak of west nile virus infection in the New York city area in 1999. NEJM 2001; 344(24): 1807-12.
173. Anticona EM, Zainah H, Ouellette DR. Two Case Reports of Neuroinvasive West Nile Virus Infection in the Critical Care Unit. Case Rep Infect Dis Vol 2012; 2012: 839458.
174. Davis LE, DeBiasi R, Goade DE. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60(3): 286-300.
175. Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007; 12: 1918-20.
176. Kumar M, Roe K, Nerurkar PV, et al. Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS One 2012; 7(8): e44682.
177. Martinez ES, Saiz M, Sobrino F. Foot-and-Charles H. Alzheimer's disease linked to the common cold. Mouth Disease Virus. Animal Viruses Mol Biol 2008; 22-6.
178. Charles, H. Alzheimer's disease linked to the common cold. Mail Online 2006; p:1. http://www.dailymail.co.uk/health/article-412145/Alzheimers-disease-linked-common-cold.html
179. Durrwald R, Ludwig H. Borna Disease Virus(BDV): a(Zoonotic?) WorlwidePathogen. A Review of the History of the Disease and the Virus Infection with Comprehensive Bibliography. J Vet Med 1997; 44(3): 147-84.
180. Ludwig H, Bode L. Borna Disease Virus: new aspects on infection, disease, diagnosis and epidemiology. Rev Sci Tech Off Int Epiz 2000; 19(1): 259-88.
181. Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H. Detection of serum antibodies to Borna Disease Virus in patients with psychiatric disorders. Science 1985; 228(4700): 755-756.
182. Volmer R, Prat CMA, Masson G, Garenne A, Gonzales-Dunia.; D. Borna Disease Virus Infection Impairs Synaptic Plasticity. J Virol 2007; 81(16): 8833-8837.
183. Solbrig MV. Animal models of CNS viral disease: Examples from Borna disease virus models. Interdiscip Perspect Infect Dis 2010; (709791): 1-6.
184. Sylva R, Lubos J. Borna disease virus and Psychiatric Disorders: Can Viruses Influence Psychiatric Disorders? Psychiatric Disord Worldwide Adv 2011; 307-833-5.